AMGN vs ABT
By Alex · Tickerpine
Amgen Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ABT |
|---|---|---|
| Price | $358.33 | $94.12 |
| Market cap | $193.39B | $163.94B |
| P/E ratio | 24.9 | 26.4 |
| ROE | 101.32% | 12.33% |
| Profit margin | 20.96% | 13.90% |
| Revenue growth | 5.80% | 7.80% |
| Dividend yield | 2.81% | 2.68% |
| Beta | 0.42 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ABT in plain English
- AMGN and ABT are similar in size.
- AMGN is cheaper on earnings (P/E 24.9 vs 26.4).
- AMGN earns a higher return on equity (101% vs 12%).
- ABT is growing revenue faster (8% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 2.68%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.